Is undifferentiated spondyloarthritis a discrete entity? A debate

Atulya (Atul) Deodhar; Pierre Miossec; Xenofon Baraliakos

doi:10.1016/j.autrev.2017.11.006

Is undifferentiated spondyloarthritis a discrete entity? A debate

Atulya (Atul) Deodhar, Pierre Miossec, Xenofon Baraliakos

Arthritis & Rheumatic Diseases

Research output: Contribution to journal › Article

5 Scopus citations

Abstract

The concept of undifferentiated spondyloarthritis has been introduced recently to describe a clinical setting where the classical features of spondyloarthritis (SpA) are not fully present. Whether this is a discrete entity was the basis of a debate during the 4th International Congress on Controversies in Rheumatology & Autoimmunity held in Bologna, Italy 9-11 March 2017. The pro and con aspects of the debate are presented. The implications of the debate are important ranging from diagnostic aspects to consequences for the society and the payers.

Original language	English (US)
Journal	Autoimmunity Reviews
DOIs	https://doi.org/10.1016/j.autrev.2017.11.006
State	Accepted/In press - Sep 10 2017

ASJC Scopus subject areas

Immunology and Allergy
Immunology

Access to Document

10.1016/j.autrev.2017.11.006

Fingerprint Dive into the research topics of 'Is undifferentiated spondyloarthritis a discrete entity? A debate'. Together they form a unique fingerprint.

Cite this

Deodhar, A. A., Miossec, P., & Baraliakos, X. (Accepted/In press). Is undifferentiated spondyloarthritis a discrete entity? A debate. Autoimmunity Reviews. https://doi.org/10.1016/j.autrev.2017.11.006

@article{3ca6a930bfb745cf854bf0f179db3269,

title = "Is undifferentiated spondyloarthritis a discrete entity? A debate",

abstract = "The concept of undifferentiated spondyloarthritis has been introduced recently to describe a clinical setting where the classical features of spondyloarthritis (SpA) are not fully present. Whether this is a discrete entity was the basis of a debate during the 4th International Congress on Controversies in Rheumatology & Autoimmunity held in Bologna, Italy 9-11 March 2017. The pro and con aspects of the debate are presented. The implications of the debate are important ranging from diagnostic aspects to consequences for the society and the payers.",

author = "Deodhar, {Atulya (Atul)} and Pierre Miossec and Xenofon Baraliakos",

year = "2017",

month = sep,

day = "10",

doi = "10.1016/j.autrev.2017.11.006",

language = "English (US)",

journal = "Autoimmunity Reviews",

issn = "1568-9972",

publisher = "Elsevier",

}

TY - JOUR

T1 - Is undifferentiated spondyloarthritis a discrete entity? A debate

AU - Deodhar, Atulya (Atul)

AU - Miossec, Pierre

AU - Baraliakos, Xenofon

PY - 2017/9/10

Y1 - 2017/9/10

N2 - The concept of undifferentiated spondyloarthritis has been introduced recently to describe a clinical setting where the classical features of spondyloarthritis (SpA) are not fully present. Whether this is a discrete entity was the basis of a debate during the 4th International Congress on Controversies in Rheumatology & Autoimmunity held in Bologna, Italy 9-11 March 2017. The pro and con aspects of the debate are presented. The implications of the debate are important ranging from diagnostic aspects to consequences for the society and the payers.

AB - The concept of undifferentiated spondyloarthritis has been introduced recently to describe a clinical setting where the classical features of spondyloarthritis (SpA) are not fully present. Whether this is a discrete entity was the basis of a debate during the 4th International Congress on Controversies in Rheumatology & Autoimmunity held in Bologna, Italy 9-11 March 2017. The pro and con aspects of the debate are presented. The implications of the debate are important ranging from diagnostic aspects to consequences for the society and the payers.

UR - http://www.scopus.com/inward/record.url?scp=85033367089&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85033367089&partnerID=8YFLogxK

U2 - 10.1016/j.autrev.2017.11.006

DO - 10.1016/j.autrev.2017.11.006

M3 - Article

C2 - 29108820

AN - SCOPUS:85033367089

JO - Autoimmunity Reviews

JF - Autoimmunity Reviews

SN - 1568-9972

ER -